Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
about
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseTransplant genetics and genomics.Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.Concepts of Genomics in Kidney Transplantation.Early Steroid Withdrawal in Black Transplant Patients: A Selective Process.Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.Health Disparities in Kidney Transplantation for African Americans.Genetics of acute rejection after kidney transplantation.Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.Prevalence of CYP3A5 Genomic Variances and Their Impact on Tacrolimus Dosing Requirements among Kidney Transplant Recipients in Eastern North Carolina.
P2860
Q37662607-32CADFCE-6609-4D08-8329-923864A55F7FQ38704635-56373082-3B94-4DC5-A178-F3F1E7D34F6AQ38787174-75F2BE60-EEAF-4238-896B-7EF4DF0AC7F1Q38865683-DE396F56-14AD-4219-8397-C90F43F7FF0CQ39175303-A3E0D92B-39DB-4062-86D2-BF25CE37B1D4Q46357849-3B125F84-1B07-48CC-8482-CF0C3B4BD4B5Q46684824-90057AE2-79F7-4ED2-8D85-4CB9C1449765Q46777368-E918AFA8-5FFF-4694-82A7-4422AC976B4DQ47436776-5B49503D-CAE9-4A2C-85CC-5C8EC4A4AA72Q47749734-B0BDF7A1-CF25-4CEC-9D41-ED6E85FE2261Q47898148-6032ED66-D0BD-47C0-BD6D-52441D5372D3Q52859440-C43E6B92-EC69-4D66-80D7-C99E5612BE5AQ53228378-3B3D867C-167B-4701-AE03-56A1E05D3123
P2860
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@en
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@nl
type
label
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@en
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@nl
prefLabel
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@en
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@nl
P2093
P2860
P356
P1476
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
@en
P2093
A K Israni
D P Schladt
K Sanghavi
M B Miller
P A Jacobson
R B Mannon
R C Brundage
R P Remmel
P2860
P2888
P356
10.1038/TPJ.2015.87
P577
2015-12-15T00:00:00Z
P6179
1037749567